Source:http://linkedlifedata.com/resource/pubmed/id/11328792
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2001-4-30
|
pubmed:abstractText |
The concentrations of cefepime in pancreatic pseudocyst fluid (n = 4), pancreatic tissue (n = 4) and pancreatic fistula fluid (n = 1), and simultaneous plasma concentrations, were measured after intravenous administration of a single 2 g dose to nine patients. Mean plasma concentration was 27.4 mg/L between 120 and 200 min after the end of infusion. Mean pancreatic cefepime concentration was 6.3 mg/L in pseudocyst and 10.7 mg/L in pancreatic tissue. Cefepime was detected by 30 min after the end of the perfusion in pancreatic fistulae fluid, and persisted at 8 h. We conclude that cefepime is a potentially useful antibiotic in prevention and treatment of pancreatic infection.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0305-7453
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
47
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
711-3
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11328792-Adult,
pubmed-meshheading:11328792-Aged,
pubmed-meshheading:11328792-Cephalosporins,
pubmed-meshheading:11328792-Female,
pubmed-meshheading:11328792-Humans,
pubmed-meshheading:11328792-Infusions, Intravenous,
pubmed-meshheading:11328792-Male,
pubmed-meshheading:11328792-Middle Aged,
pubmed-meshheading:11328792-Pancreatitis
|
pubmed:year |
2001
|
pubmed:articleTitle |
Pancreatic concentrations of cefepime.
|
pubmed:affiliation |
Services d'Hépatogastroentérologie, Centre Hospitalo-Universitaire Nord, 80054 Amiens Cedex, France. delcenserie.richard@chu-amiens.fr
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|